Skip to main content
Erschienen in: Cancer Causes & Control 8/2015

01.08.2015 | Original paper

Bone cancer incidence by morphological subtype: a global assessment

verfasst von: Patricia C. Valery, Mathieu Laversanne, Freddie Bray

Erschienen in: Cancer Causes & Control | Ausgabe 8/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To better understand the relevance of environmental factors to the changing patterns of bone cancer subtypes, we examine the incidence of osteosarcoma (OS), Ewing sarcoma (ES), and chondrosarcoma (CS) using data from cancer incidence in five continents.

Methods

Age-specific and age-standardized incidence rates (ASRs) per 100,000 person-years were computed and stratified by country (n = 43), subtype, and sex during 2003–2007. Temporal patterns of ASRs were examined during 1988–2007 (12 countries). Age–period–cohort models were fitted for the USA and UK by subtype.

Results

For most countries, OS represented 20–40 % of all bone cancers, ES < 20 %, while CS proportions varied more considerably. Overall ASRs of bone cancers were 0.8–1.2/100,000 in men and 0.5–1.0 in women (0.20–0.35/100,000 for OS and 0.10–0.30/100,000 for CS in both men and women, and <0.10–0.25/100,000 in men and 0.05–0.25/100,000 in women for ES). The age-specific incidence rates revealed a bimodal peak of OS, one peak of ES in childhood, and a more heterogeneous pattern for CS. The overall bone cancer incidence trends are generally flat, but more heterogeneous for ES and CS. A declining OS incidence was observed in the UK and USA (men), an increase in CS in the UK and USA (female), and an apparent increase in ES, followed by a leveling off in successive US and UK cohorts.

Conclusion

Monitoring bone cancer incidence trends with data assembled from a geographically broader range of registries may generate hypotheses about additional risk factors and ensure that high-risk populations are not overlooked in cancer control efforts.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat International Agency for Research on Cancer (2013) Cancer incidence in five continents, volume X (electronic version). In: Forman D, Bray F, Brewster D, Mbalawa CG, Kohler B, Piñeros M, Steliarova-Foucher E, Swaminathan R, Ferlay J (eds). IARC, Lyon http://ci5.iarc.fr. Accessed 10 Jan 2014 International Agency for Research on Cancer (2013) Cancer incidence in five continents, volume X (electronic version). In: Forman D, Bray F, Brewster D, Mbalawa CG, Kohler B, Piñeros M, Steliarova-Foucher E, Swaminathan R, Ferlay J (eds). IARC, Lyon http://​ci5.​iarc.​fr. Accessed 10 Jan 2014
2.
Zurück zum Zitat Miller RW, Boice JD, Curtis RE (2006) Cancer epidemiology and prevention. In: Schottenfeld D, Fraumeni FJ (eds) Cancer epidemiology and prevention, 3rd edn. Oxford University Press, New York, pp 946–958CrossRef Miller RW, Boice JD, Curtis RE (2006) Cancer epidemiology and prevention. In: Schottenfeld D, Fraumeni FJ (eds) Cancer epidemiology and prevention, 3rd edn. Oxford University Press, New York, pp 946–958CrossRef
3.
Zurück zum Zitat Le Vu B, de Vathaire F, Shamsaldin A et al (1998) Radiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhood. Int J Cancer 77:370–377PubMedCrossRef Le Vu B, de Vathaire F, Shamsaldin A et al (1998) Radiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhood. Int J Cancer 77:370–377PubMedCrossRef
4.
Zurück zum Zitat Hawkins MM, Wilson LM, Burton HS et al (1996) Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer. J Natl Cancer Inst 88:270–278PubMedCrossRef Hawkins MM, Wilson LM, Burton HS et al (1996) Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer. J Natl Cancer Inst 88:270–278PubMedCrossRef
5.
Zurück zum Zitat Finkelstein MM, Kreiger N (1996) Radium in drinking water and risk of bone cancer in Ontario youths: a second study and combined analysis. Occup Environ Med 53:305–311PubMedCentralPubMedCrossRef Finkelstein MM, Kreiger N (1996) Radium in drinking water and risk of bone cancer in Ontario youths: a second study and combined analysis. Occup Environ Med 53:305–311PubMedCentralPubMedCrossRef
6.
Zurück zum Zitat Hum L, Kreiger N, Finkelstein MM (1998) The relationship between parental occupation and bone cancer risk in offspring. Int J Epidemiol 27:766–771PubMedCrossRef Hum L, Kreiger N, Finkelstein MM (1998) The relationship between parental occupation and bone cancer risk in offspring. Int J Epidemiol 27:766–771PubMedCrossRef
7.
Zurück zum Zitat Troisi R, Masters MN, Joshipura K, Douglass C, Cole BF, Hoover RN, The National Osteosarcoma Etiology Group (2006) Perinatal factors, growth and development, and osteosarcoma risk. Br J Cancer 95:1603–1607PubMedCentralPubMedCrossRef Troisi R, Masters MN, Joshipura K, Douglass C, Cole BF, Hoover RN, The National Osteosarcoma Etiology Group (2006) Perinatal factors, growth and development, and osteosarcoma risk. Br J Cancer 95:1603–1607PubMedCentralPubMedCrossRef
8.
Zurück zum Zitat Mirabello L, Pfeiffer R, Murphy G, Daw NC, Patino-Garcia A, Troisi RJ, Hoover RN, Douglass C, Schuz J, Craft AW, Savage SA (2011) Height at diagnosis and birth-weight as risk factors for osteosarcoma. Cancer Causes Control 22:899–908PubMedCentralPubMedCrossRef Mirabello L, Pfeiffer R, Murphy G, Daw NC, Patino-Garcia A, Troisi RJ, Hoover RN, Douglass C, Schuz J, Craft AW, Savage SA (2011) Height at diagnosis and birth-weight as risk factors for osteosarcoma. Cancer Causes Control 22:899–908PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat Bassin EB, Wypij D, Davis RB, Mittleman MA (2006) Age-specific fluoride exposure in drinking water and osteosarcoma (United States). Cancer Causes Control 17:421–428PubMedCrossRef Bassin EB, Wypij D, Davis RB, Mittleman MA (2006) Age-specific fluoride exposure in drinking water and osteosarcoma (United States). Cancer Causes Control 17:421–428PubMedCrossRef
10.
Zurück zum Zitat Blakey K, Feltbower RG, Parslow RC, James PW, Gomez Pozo B, Stiller C, Vincent TJ, Norman P, McKinney PA, Murphy MF, Craft AW, McNally RJ (2014) Is fluoride a risk factor for bone cancer? Small area analysis of osteosarcoma and Ewing sarcoma diagnosed among 0–49-year-olds in Great Britain, 1980–2005. Int J Epidemiol 43:224–234PubMedCentralPubMedCrossRef Blakey K, Feltbower RG, Parslow RC, James PW, Gomez Pozo B, Stiller C, Vincent TJ, Norman P, McKinney PA, Murphy MF, Craft AW, McNally RJ (2014) Is fluoride a risk factor for bone cancer? Small area analysis of osteosarcoma and Ewing sarcoma diagnosed among 0–49-year-olds in Great Britain, 1980–2005. Int J Epidemiol 43:224–234PubMedCentralPubMedCrossRef
11.
Zurück zum Zitat Moore LE, Gold L, Stewart PA, Gridley G, Prince JR, Zahm SH (2005) Parental occupational exposures and Ewing’s sarcoma. Int J Cancer 114:472–478PubMedCrossRef Moore LE, Gold L, Stewart PA, Gridley G, Prince JR, Zahm SH (2005) Parental occupational exposures and Ewing’s sarcoma. Int J Cancer 114:472–478PubMedCrossRef
12.
Zurück zum Zitat Valery P, McWhirter W, Sleigh A, Williams G, Bain C (2002) Farm exposures, parental occupation and risk of Ewing’s sarcoma in Australia: a national case-control study. Cancer Causes Control 13:263–270PubMedCrossRef Valery P, McWhirter W, Sleigh A, Williams G, Bain C (2002) Farm exposures, parental occupation and risk of Ewing’s sarcoma in Australia: a national case-control study. Cancer Causes Control 13:263–270PubMedCrossRef
13.
Zurück zum Zitat Holly EA, Aston DA, Ann DK, Kristiansen JJ (1992) Ewing’s bone sarcoma, paternal occupational exposure, and other factors. Am J Epidemiol 135(2):122–129 Holly EA, Aston DA, Ann DK, Kristiansen JJ (1992) Ewing’s bone sarcoma, paternal occupational exposure, and other factors. Am J Epidemiol 135(2):122–129
14.
Zurück zum Zitat Winn DM, Li FP, Robison LL, Mulvihill JJ, Daigle AE, Fraumeni JF Jr (1992) A case-control study of the etiology of Ewing’s sarcoma. Cancer Epidemiol Biomarkers Prev 1:525–532PubMed Winn DM, Li FP, Robison LL, Mulvihill JJ, Daigle AE, Fraumeni JF Jr (1992) A case-control study of the etiology of Ewing’s sarcoma. Cancer Epidemiol Biomarkers Prev 1:525–532PubMed
15.
Zurück zum Zitat Valery PC, Holly EA, Sleigh AC, Williams G, Kreiger N, Bain C (2005) Hernias and Ewing’s sarcoma family of tumours: a pooled analysis and meta-analysis. Lancet Oncol 6:485–490PubMedCrossRef Valery PC, Holly EA, Sleigh AC, Williams G, Kreiger N, Bain C (2005) Hernias and Ewing’s sarcoma family of tumours: a pooled analysis and meta-analysis. Lancet Oncol 6:485–490PubMedCrossRef
16.
Zurück zum Zitat Bovee JV, Hogendoorn PC, Wunder JS, Alman BA (2010) Cartilage tumours and bone development: molecular pathology and possible therapeutic targets. Nat Rev Cancer 10:481–488PubMedCrossRef Bovee JV, Hogendoorn PC, Wunder JS, Alman BA (2010) Cartilage tumours and bone development: molecular pathology and possible therapeutic targets. Nat Rev Cancer 10:481–488PubMedCrossRef
17.
Zurück zum Zitat Savage SA, Burdett L, Troisi R, Douglass C, Hoover RN, Chanock SJ (2007) Germ-line genetic variation of TP53 in osteosarcoma. Pediatr Blood Cancer 49:28–33PubMedCrossRef Savage SA, Burdett L, Troisi R, Douglass C, Hoover RN, Chanock SJ (2007) Germ-line genetic variation of TP53 in osteosarcoma. Pediatr Blood Cancer 49:28–33PubMedCrossRef
18.
Zurück zum Zitat Savage SA, Woodson K, Walk E et al (2007) Analysis of genes critical for growth regulation identifies insulin-like Growth Factor 2 Receptor variations with possible functional significance as risk factors for osteosarcoma. Cancer Epidemiol Biomarkers Prev 16:1667–1674PubMedCrossRef Savage SA, Woodson K, Walk E et al (2007) Analysis of genes critical for growth regulation identifies insulin-like Growth Factor 2 Receptor variations with possible functional significance as risk factors for osteosarcoma. Cancer Epidemiol Biomarkers Prev 16:1667–1674PubMedCrossRef
19.
Zurück zum Zitat Savage SA, Mirabello L, Wang Z et al (2013) Genome-wide association study identifies two susceptibility loci for osteosarcoma. Nat Genet 45:799–803PubMedCentralPubMedCrossRef Savage SA, Mirabello L, Wang Z et al (2013) Genome-wide association study identifies two susceptibility loci for osteosarcoma. Nat Genet 45:799–803PubMedCentralPubMedCrossRef
20.
Zurück zum Zitat Liu Y, He Z, Feng D, Shi G, Gao R, Wu X, Song W, Yuan W (2011) Cytotoxic T-lymphocyte antigen-4 polymorphisms and susceptibility to osteosarcoma. DNA Cell Biol 30:1051–1055PubMedCrossRef Liu Y, He Z, Feng D, Shi G, Gao R, Wu X, Song W, Yuan W (2011) Cytotoxic T-lymphocyte antigen-4 polymorphisms and susceptibility to osteosarcoma. DNA Cell Biol 30:1051–1055PubMedCrossRef
21.
22.
Zurück zum Zitat Wang Q, Lei C, Wan H, Liu Q (2012) Improved cellular immune response elicited by a ubiquitin-fused DNA vaccine against Mycobacterium tuberculosis. DNA Cell Biol 31:489–495PubMedCrossRef Wang Q, Lei C, Wan H, Liu Q (2012) Improved cellular immune response elicited by a ubiquitin-fused DNA vaccine against Mycobacterium tuberculosis. DNA Cell Biol 31:489–495PubMedCrossRef
23.
Zurück zum Zitat Silva DS, Sawitzki FR, De Toni EC, Graebin P, Picanco JB, Abujamra AL, de Farias CB, Roesler R, Brunetto AL, Alho CS (2012) Ewing’s sarcoma: analysis of single nucleotide polymorphism in the EWS gene. Gene 509:263–266PubMedCrossRef Silva DS, Sawitzki FR, De Toni EC, Graebin P, Picanco JB, Abujamra AL, de Farias CB, Roesler R, Brunetto AL, Alho CS (2012) Ewing’s sarcoma: analysis of single nucleotide polymorphism in the EWS gene. Gene 509:263–266PubMedCrossRef
24.
Zurück zum Zitat World Health Organization (2000) International classification of diseases for oncology (ICD-0), 3rd ed. In: Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, Whelan S (eds). World Health Organization, Geneva World Health Organization (2000) International classification of diseases for oncology (ICD-0), 3rd ed. In: Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, Whelan S (eds). World Health Organization, Geneva
25.
Zurück zum Zitat Segi M (1960) Cancer mortality for selected sites in 24 countries (1950–57). In: Department of Public Health. Tohoku University of Medicine, Sendai, Japan Segi M (1960) Cancer mortality for selected sites in 24 countries (1950–57). In: Department of Public Health. Tohoku University of Medicine, Sendai, Japan
26.
Zurück zum Zitat Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J (eds) (1997) Cancer incidence in five continents, vol. VII (IARC Scientific Publications, No. 143). IARC, Lyon, France Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J (eds) (1997) Cancer incidence in five continents, vol. VII (IARC Scientific Publications, No. 143). IARC, Lyon, France
27.
Zurück zum Zitat Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB (eds) (2002) Cancer incidence in five continents, vol. VIII (IARC Scientific Publications, No. 155). IARC, Lyon, France Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB (eds) (2002) Cancer incidence in five continents, vol. VIII (IARC Scientific Publications, No. 155). IARC, Lyon, France
28.
Zurück zum Zitat Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P (eds) (2007) Cancer incidence in five continents, vol. IX (IARC Scientific Publications, No. 160). IARC, Lyon, France Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P (eds) (2007) Cancer incidence in five continents, vol. IX (IARC Scientific Publications, No. 160). IARC, Lyon, France
29.
Zurück zum Zitat Clayton D, Schifflers E (1987) Models for temporal variation in cancer rates. I: age-period and age-cohort models. Stat Med 6:449–467PubMedCrossRef Clayton D, Schifflers E (1987) Models for temporal variation in cancer rates. I: age-period and age-cohort models. Stat Med 6:449–467PubMedCrossRef
30.
Zurück zum Zitat Clayton D, Schifflers E (1987) Models for temporal variation in cancer rates. II: age-cohort models. Stat Med 6:469–481PubMedCrossRef Clayton D, Schifflers E (1987) Models for temporal variation in cancer rates. II: age-cohort models. Stat Med 6:469–481PubMedCrossRef
31.
Zurück zum Zitat StataCorp (2011) Stata statistical software: release 12. StataCorp LP, College Station StataCorp (2011) Stata statistical software: release 12. StataCorp LP, College Station
32.
Zurück zum Zitat Anfinsen KP, Devesa SS, Bray F, Troisi R, Jonasdottir TJ, Bruland OS, Grotmol T (2011) Age-period-cohort analysis of primary bone cancer incidence rates in the United States (1976–2005). Cancer Epidemiol Biomarkers Prev 20:1770–1777PubMedCrossRef Anfinsen KP, Devesa SS, Bray F, Troisi R, Jonasdottir TJ, Bruland OS, Grotmol T (2011) Age-period-cohort analysis of primary bone cancer incidence rates in the United States (1976–2005). Cancer Epidemiol Biomarkers Prev 20:1770–1777PubMedCrossRef
33.
Zurück zum Zitat Cavelaars AE, Kunst AE, Geurts JJ, Crialesi R, Grotvedt L, Helmert U, Lahelma E, Lundberg O, Mielck A, Rasmussen NK, Regidor E, Spuhler T, Mackenbach JP (2000) Persistent variations in average height between countries and between socio-economic groups: an overview of 10 European countries. Ann Hum Biol 27:407–421PubMedCrossRef Cavelaars AE, Kunst AE, Geurts JJ, Crialesi R, Grotvedt L, Helmert U, Lahelma E, Lundberg O, Mielck A, Rasmussen NK, Regidor E, Spuhler T, Mackenbach JP (2000) Persistent variations in average height between countries and between socio-economic groups: an overview of 10 European countries. Ann Hum Biol 27:407–421PubMedCrossRef
34.
Zurück zum Zitat Huvos AG (1986) Osteogenic sarcoma of bones and soft tissues in older persons. A clinicopathologic analysis of 117 patients older than 60 years. Cancer 57:1442–1449PubMedCrossRef Huvos AG (1986) Osteogenic sarcoma of bones and soft tissues in older persons. A clinicopathologic analysis of 117 patients older than 60 years. Cancer 57:1442–1449PubMedCrossRef
35.
Zurück zum Zitat Mirabello L, Troisi RJ, Savage SA (2009) Osteosarcoma incidence and survival rates from 1973 to 2004: data from the surveillance, epidemiology, and end results program. Cancer 115:1531–1543PubMedCentralPubMedCrossRef Mirabello L, Troisi RJ, Savage SA (2009) Osteosarcoma incidence and survival rates from 1973 to 2004: data from the surveillance, epidemiology, and end results program. Cancer 115:1531–1543PubMedCentralPubMedCrossRef
36.
Zurück zum Zitat Corral-Gudino L, Borao-Cengotita-Bengoa M, Del Pino-Montes J, Ralston S (2013) Epidemiology of Paget’s disease of bone: a systematic review and meta-analysis of secular changes. Bone 55:347–352PubMedCrossRef Corral-Gudino L, Borao-Cengotita-Bengoa M, Del Pino-Montes J, Ralston S (2013) Epidemiology of Paget’s disease of bone: a systematic review and meta-analysis of secular changes. Bone 55:347–352PubMedCrossRef
37.
Zurück zum Zitat Wang WC, Cheng YS, Chen CH, Lin YJ, Chen YK, Lin LM (2005) Paget’s disease of bone in a Chinese patient: a case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 99:727–733PubMedCrossRef Wang WC, Cheng YS, Chen CH, Lin YJ, Chen YK, Lin LM (2005) Paget’s disease of bone in a Chinese patient: a case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 99:727–733PubMedCrossRef
38.
Zurück zum Zitat Okada K, Hasegawa T, Nishida J, Ogose A, Tajino T, Osanai T, Yanagisawa M, Hatori M (2004) Osteosarcomas after the age of 50: a clinicopathologic study of 64 cases—an experience in northern Japan. Ann Surg Oncol 11:998–1004PubMedCrossRef Okada K, Hasegawa T, Nishida J, Ogose A, Tajino T, Osanai T, Yanagisawa M, Hatori M (2004) Osteosarcomas after the age of 50: a clinicopathologic study of 64 cases—an experience in northern Japan. Ann Surg Oncol 11:998–1004PubMedCrossRef
39.
Zurück zum Zitat McKusick VA (1994) Medical genetics at Johns Hopkins: past, present and future, 11th edn. Johns Hopkins University Press, Baltimore McKusick VA (1994) Medical genetics at Johns Hopkins: past, present and future, 11th edn. Johns Hopkins University Press, Baltimore
40.
Zurück zum Zitat Gardner M, Guyer P, Barker D (1978) Radiological prevalence of Paget’s disease of bone in British migrants to Australia. Br Med J 1:1655–1657PubMedCentralPubMedCrossRef Gardner M, Guyer P, Barker D (1978) Radiological prevalence of Paget’s disease of bone in British migrants to Australia. Br Med J 1:1655–1657PubMedCentralPubMedCrossRef
41.
Zurück zum Zitat Armstrong G, Stovallb M, Robinson L (2010) Long-term effects of radiation exposure among adult survivors of childhood cancer: results from the childhood cancer survivor study. Radiat Res 174:840–850PubMedCentralPubMedCrossRef Armstrong G, Stovallb M, Robinson L (2010) Long-term effects of radiation exposure among adult survivors of childhood cancer: results from the childhood cancer survivor study. Radiat Res 174:840–850PubMedCentralPubMedCrossRef
43.
Zurück zum Zitat Palumbo A, Bringhen S, Kumar SK, Lupparelli G, Usmani S, Waage A, Larocca A, van der Holt B, Musto P, Offidani M, Petrucci MT, Evangelista A, Zweegman S, Nooka AK, Spencer A, Dimopoulos MA, Hajek R, Cavo M, Richardson P, Lonial S, Ciccone G, Boccadoro M, Anderson K, Barlogie B, Sonneveld P, McCarthy PL (2014) Second primary malignancies with lenalidomide therapy for newly diagnosed myeloma: a meta-analysis of individual patient data. Lancet Oncol 15:333–342PubMedCrossRef Palumbo A, Bringhen S, Kumar SK, Lupparelli G, Usmani S, Waage A, Larocca A, van der Holt B, Musto P, Offidani M, Petrucci MT, Evangelista A, Zweegman S, Nooka AK, Spencer A, Dimopoulos MA, Hajek R, Cavo M, Richardson P, Lonial S, Ciccone G, Boccadoro M, Anderson K, Barlogie B, Sonneveld P, McCarthy PL (2014) Second primary malignancies with lenalidomide therapy for newly diagnosed myeloma: a meta-analysis of individual patient data. Lancet Oncol 15:333–342PubMedCrossRef
44.
Zurück zum Zitat Egas-Bejar D, Huh W (2014) Rhabdomyosarcoma in adolescent and young adult patients: current perspectives. Adolesc Health Med Ther 5:115–125PubMedCentralPubMed Egas-Bejar D, Huh W (2014) Rhabdomyosarcoma in adolescent and young adult patients: current perspectives. Adolesc Health Med Ther 5:115–125PubMedCentralPubMed
45.
Zurück zum Zitat Inskip P, Robison L, Stovall M, Smith S, Hammond S, Mertens A, Whitton J, Diller L, Kenney L, Neglia J (2009) Radiation dose and breast cancer risk in the childhood cancer survivor study. J Clin Oncol 27:3901–3907PubMedCentralPubMedCrossRef Inskip P, Robison L, Stovall M, Smith S, Hammond S, Mertens A, Whitton J, Diller L, Kenney L, Neglia J (2009) Radiation dose and breast cancer risk in the childhood cancer survivor study. J Clin Oncol 27:3901–3907PubMedCentralPubMedCrossRef
46.
Zurück zum Zitat Chung K, Keating N, Yock T, Tarbell N (2008) Comparative analysis of second malignancy risk in patients treated with proton therapy versus conventional photon therapy. Int J Radiat Oncol Biol Phys 72:S8CrossRef Chung K, Keating N, Yock T, Tarbell N (2008) Comparative analysis of second malignancy risk in patients treated with proton therapy versus conventional photon therapy. Int J Radiat Oncol Biol Phys 72:S8CrossRef
47.
Zurück zum Zitat Kozak K, Adams J, Krejcarek S, Tarbell N, Yock T (2009) A dosimetric comparison of proton and intensity-modulated photon radiotherapy for pediatric parameningeal rhabdomyosarcomas. Int J Radiat Oncol Biol Phys 74(1):179–186 Kozak K, Adams J, Krejcarek S, Tarbell N, Yock T (2009) A dosimetric comparison of proton and intensity-modulated photon radiotherapy for pediatric parameningeal rhabdomyosarcomas. Int J Radiat Oncol Biol Phys 74(1):179–186
48.
Zurück zum Zitat MacDonald S, Safai S, Trofimov A, Wolfgang J, Fullerton B, Yeap B, Bortfeld T, Tarbell N, Yock T (2008) Proton radiotherapy for childhood ependymoma: initial clinical outcomes and dose comparisons. Int J Radiat Oncol Biol Phys 71:979–986PubMedCrossRef MacDonald S, Safai S, Trofimov A, Wolfgang J, Fullerton B, Yeap B, Bortfeld T, Tarbell N, Yock T (2008) Proton radiotherapy for childhood ependymoma: initial clinical outcomes and dose comparisons. Int J Radiat Oncol Biol Phys 71:979–986PubMedCrossRef
49.
Zurück zum Zitat Mirabello L, Troisi RJ, Savage SA (2009) International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons. Int J Cancer 125:229–234PubMedCentralPubMedCrossRef Mirabello L, Troisi RJ, Savage SA (2009) International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons. Int J Cancer 125:229–234PubMedCentralPubMedCrossRef
50.
Zurück zum Zitat Bovee JV, Cleton-Jansen AM, Taminiau AH, Hogendoorn PC (2005) Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment. Lancet Oncol 6:599–607PubMedCrossRef Bovee JV, Cleton-Jansen AM, Taminiau AH, Hogendoorn PC (2005) Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment. Lancet Oncol 6:599–607PubMedCrossRef
51.
Zurück zum Zitat Meijer D, Gelderblom H, Karperien M, Cleton-Jansen AM, Hogendoorn PC, Bovee JV (2011) Expression of aromatase and estrogen receptor alpha in chondrosarcoma, but no beneficial effect of inhibiting estrogen signaling both in vitro and in vivo. Clin Sarcoma Res 1:5PubMedCentralPubMedCrossRef Meijer D, Gelderblom H, Karperien M, Cleton-Jansen AM, Hogendoorn PC, Bovee JV (2011) Expression of aromatase and estrogen receptor alpha in chondrosarcoma, but no beneficial effect of inhibiting estrogen signaling both in vitro and in vivo. Clin Sarcoma Res 1:5PubMedCentralPubMedCrossRef
52.
Zurück zum Zitat Bray F, Znaor A, Cueva P, Korir A, Swaminathan R, Ullrich A, Wand S, Parkin D (2014) Quality control at the population-based cancer registry. In: Planning and developing population-based cancer registration in low- and middle-income settings (IARC Technical Publication no. 43). International Agency for Research on Cancer (IARC), Lyon, France, pp 21–26 Bray F, Znaor A, Cueva P, Korir A, Swaminathan R, Ullrich A, Wand S, Parkin D (2014) Quality control at the population-based cancer registry. In: Planning and developing population-based cancer registration in low- and middle-income settings (IARC Technical Publication no. 43). International Agency for Research on Cancer (IARC), Lyon, France, pp 21–26
Metadaten
Titel
Bone cancer incidence by morphological subtype: a global assessment
verfasst von
Patricia C. Valery
Mathieu Laversanne
Freddie Bray
Publikationsdatum
01.08.2015
Verlag
Springer International Publishing
Erschienen in
Cancer Causes & Control / Ausgabe 8/2015
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-015-0607-3

Weitere Artikel der Ausgabe 8/2015

Cancer Causes & Control 8/2015 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.